WHO Pauses Trial of Hydroxychloroquine in COVID-19 Patients Due to Safety Concerns
1 month ago - By Medscape
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.
Reuters Health Information
Read more ...
WHO Stops Study Of Hydroxychloroquine Trial Over Safety Concerns
1 month ago - By Scary Mommy
The study was published in The Lancet late last week
The World Health Organization is pausing clinical t rials that use hydroxychloroquine to treat COVID-19 patients after a medical journal published a paper last week stating patients taking hydroxychloroquine were dying at higher rates than those who were not.
The Lancet reported that, not only did researchers not observe “ any benefit of hydroxychloroquine or chloroquine (when used alone or in combination with a macrolide) on in-hospital outcomes,” but that “ventricular arrhythmias were more common and mortality was higher” in the groups...
Read more ...
Oxford Covid-19 trial of Trump-backed hydroxychloroquine is CONTINUING despite death fears
1 month ago - By Daily Mail
Oxford University researchers were given the green light by the UK drugs watchdog to continue giving the tablets to NHS patients with COVID-19 as part of the Recovery Trial.
Read more ...
The headlines of Master Doctor
Will a Covid mask starve your brain of oxygen?
A study found that face coverings reduce the risk of coronavirus transmission by a third, though some people on the internet fear using protection will cause them brain damage.
COVID-19 in New York: Confirmed Cases Top 400,000
The confirmed cases of COVID-19 in New York have topped 400,000, reaching 400,299 with a death toll of 32,307, reveals data source.
Fat Cell Hormone can Boost Potential of Stem Cell Therapy
Adiponectin, a hormone derived from fat cells, improves mesenchymal stem cell-based treatment of heart failure, finds a new study.
Excess Deaths from COVID-19; Getting to Herd Immunity: It's TTHealthWatch!
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine, and Rick Lange, MD, president of the Texas...
Family Planning During COVID-19
World population day: It's time to bring back the 'choice, voice debate' on family planning during coronavirus pandemic.
On a keto diet? Satisfy that sweet tooth with these keto-approved sweeteners
The keto diet may seem daunting to anyone who loves carbs and sweets. After all, dieting means being careful about what you eat. However, there are many ways to make dishes...
IMedicalApps: COVID-19 Protocols
Recently, Brigham and Women's Hospital released a comprehensive app of all of its COVID-19 clinical guidelines, called COVID Protocols, which are also available online. This...
Why Lopinavir and Hydroxychloroquine are Ineffective Against COVID-19
Lopinavir and Hydroxychloroquine do not work on COVID-19 because the concentration of both these drugs in the lungs of patients are not sufficient to fight the infection...
Drug May Help to Extend Lifespan in Humans
Mifepristone, a drug used to treat cancer, Cushing syndrome, and also used to terminate pregnancies, may have the potential to increase human lifespan. It does so by reducing...
Abnormally High Fasting Blood Sugar Could Double Death Risk in COVID-19 Patients
COVID-19 patients with abnormally high blood sugar are linked to double the risk of death and an increased risk of severe complications, according to a new study.